In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nereus Pharmaceuticals Inc.

Division of Triphase Accelerator Corp.
www.nereuspharm.com

Latest From Nereus Pharmaceuticals Inc.

China IPO Roundup: Strong Spring Financings For Pharma And Biotech

China’s healthcare sector was back to actively raising proceeds from the capital markets in March and April, which witnessed more than 20 IPOs in total, with a stream of other listings being planned.

China Financing

Start-Up Quarterly Statistics: Early Funding Declined, But Deal Dollars Flowed

A review of biopharma startup dealmaking and financing activity from January through March 2017, based on data from Strategic Transactions, showed a 19% decline in startup financing compared with the fourth quarter of 2016, but big pharmas provided capital in the form of alliance fees.

StartUps and SMEs Financing

Array hires Howard Holden as VP

Array BioPharma, a company focused on discovering and developing targeted small-molecule drugs to treat cancer and inflammatory diseases has appointed Dr Howard Holden vice-president of regulatory affairs and quality assurance. Dr Holden served as senior vice-president of regulatory affairs and compliance at Nereus Pharmaceuticals from 2005-2012.

Cancer

Natural Products: Back In Vogue?

Several small biotechs are heading back to nature, spotting promising drug targets in exotic plants, sea creatures, and venomous animals, even as Big Pharma and venture capital remain skeptical of the approach.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Triphase Accelerator Corp.
  • Senior Management
  • Kobi Sethna, Pres. & CEO
    Donald Salz, VP, Fin. & Admin.
    Charles White, PhD, CBO
    G. Kenneth Lloyd, PhD, SVP, R&D & CSO
  • Contact Info
  • Nereus Pharmaceuticals Inc.
    Phone: (858) 587-4090
    10480 Wateridge Cir.
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register